Publications for Martha M. Rumore martha.rumore@touro.edu
Rumore, M. M., & Vogenberg, F. R. (2017). The HEAT initiative is gaining momentum. P & T, 42(5), 330-335. This material can be found here.
Vogenberg, F. R., Marcoux, R., & Rumore, M. M. (2017). Systemic market and organizational changes: Impact on P&T committees. P & T, 42(1), 28-32. This material can be found here.
Wittman, D., Kovera, C., Sullivan, M., & Rumore, M. M. (2017). Incorporating a drug information consult into a pharmacy practice course to build literature search and evaluation skills through a 3-stage model. Journal of Pharmacy Practice, 30(3), 306-312. https://doi.org/10.1177/0897190016637793
Cohen, K. R., Salbu, R. L., Addo-Atuah, J., & Rumore, M. M. (2016). An examination of drug-induced pulmonary disorders. U. S. Pharmacist, 41(7), 35-39. This material can be found here.
Rumore, M. M. (2016). Medication repurposing in pediatric patients: Teaching old drugs new tricks. Journal of Pediatric Pharmacology and Therapeutics, 21(1), 36-53. doi:10.5863/1551-6776-21.1.36
Rumore, M. M. (2016). The course syllabus: Legal contract or operator's manual? American Journal of Pharmaceutical Education, 80(10) [Article 177]. This material can be found here.
Rumore, M. M., & Vogenberg, F. R. (2016). Biosimilars: Still not quite ready for prime time. P & T, 41(6), 366, 368-375. This material can be found here.
Rumore, M. M., Cobb, E., Sullivan, M., & Wittman, D. (2016). Biosimilars: Opportunities and challenges for nurse practitioners. Journal for Nurse Practitioners, 12(3), 181-191. doi:10.1016/j.nurpra.2015.08.027
Rumore, M. M., Su, S., & Pellinen, J. (2016). Cyclophosphamide for suspected primary angiitis of the central nervous system in a patient with human immunodeficiency virus: A case report. International Journal of Case Reports and Images, 7(10), 644-652. This material can be found here.
Vogenberg, F. R., & Rumore, M. M. (2016). Oncology biosimilars: Opportunity or not? Value-Based Cancer Care, 7(3). This material can be found here.
Rumore, M. M., Assefa, H., Basu, P., Kumar, P., & Patel, Y. (2015). Analysis of MedWatch alerts 2009-2014. Journal of the American Pharmacists Association, 55(2), e233-e234. doi:10.1331/JAPhA.2015.15515
Rumore, M. M., Choy, M., & Cohen, K. (2015). Medication repurposing in pediatric patients: Teaching old drugs new tricks. Journal of the American Pharmacists Association, 55(2), e240. doi:10.1331/JAPhA.2015.15515
Veltri, K., Callaghan, S., Fisher, J., Rumore, M. M., Salbu, R. L., Warwick, S., Wittman, D., & Soliman, S. (2015). Meeting faculty development needs via inclusive processes in a new established college of pharmacy via inclusion processes. American Journal of Pharmaceutical Education, 79(5) [Article S4]. doi:10.5688/ajpe795S4
Guerra, J., Ligniti, E., & Rumore, M. M. (2014). Palivizumab performance improvement initiative in a neonatal intensive care unit setting. Journal of the American Pharmacists Association, 54(2), e119. doi:10.1331/JAPhA.2014.14511
Rumore, M. M. (2014). Legal aspects of drug information practice. In P. M. Malone, K. L. Kier, J. E. Stanovich, & M. J. Malone (Eds.) Drug information: A guide for pharmacists (5th ed., pp. 503-568). New York, NY: McGraw-Hill.
Rumore, M. M., & Houst, B. M. (2014). Palytoxin poisoning via inhalation in pediatric siblings. International Journal of Case Reports and Images, 5(7), 501-504. doi:10.5348/ijcri-201488-CR-10399
Rumore, M. M., & Sussman, R. (2014). Ceftriaxone safety in the pediatric population. Journal of the American Pharmacists Association, 54(2), e192. doi:10.1331/JAPhA.2014.14511
Samide, J., & Rumore, M. M. (2014). Intravenous acetaminophen usage in pediatric patients. Journal of the American Pharmacists Association, 54(2), e197. doi:10.1331/JAPhA.2014.14511
Slattery, E., Rumore, M. M., Douglas, J. S., & Seres, D. S. (2014). 3-in-1 vs 2-in-1 parenteral nutrition in adults: A review. Nutrition in Clinical Practice, 29(5), 631-635. doi:10.1177/0884533614533611
Rumore, M. M. (2013). Post Caronia: Is a new paradigm needed for off-label medication usage? Journal of Medical Marketing, 13(4), 212-220. doi:10.1177/1745790414526613
Patel, M., Rumore, M. M. (2012). Anaphylaxis with tissue plasminogen activator: Case report and literature review. Blood Coagulation & Fibrinolysis, 23(6), 568-570. doi:10.1097/MBC.0b013e32835510c2
Patel, Y., & Rumore, M. M. (2012). Hydroxyprogesterone caproate injection (makena) one year later: To compound or not to compound-that is the question. Pharmacy and Therapeutics, 37(7), 405-411. PMCID: PMC3411212
Rumore, M. M., & Vaidean, G. D. (2012). Development of a risk assessment tool for falls prevention in hospital inpatients based on the Medication Appropriateness Index (MAI) and Modified Beer’s Criteria. Innovations in Pharmacy, 3(1) [Article 73]. This material can be found here.
